Helping The others Realize The Advantages Of "3
All enrolled sufferers who gained at the least one dose of zosuquidar or placebo all through induction had been monitored for that incidence of adverse situations (439 patients, 219 on zosuquidar and 210 on placebo). The most common adverse functions were linked to the period of prolonged and considerable myelosuppression as is predicted with induc